G2Alphabet






Eli Lilly eyes stake in AI drug developer BenevolentAI

BenevolentAI, the British-based technology company which uses artificial intelligence to aid the drug discovery process, is close to securing a major strategic investment from Eli Lilly, the global pharmaceutical giant.
Source

Posted 2020/12/18 11:25:00